Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on August 11, 2008
JNCI Journal of the National Cancer Institute 2008 100(16):1129-1131; doi:10.1093/jnci/djn301
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/16/1129    most recent
djn301v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by McNeil, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNeil, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008.

NEWS

No Rest for Fatigue Researchers

Caroline McNeil

The first 150 words of the full text of this article appear below.

Fatigue is the most important side effect of cancer and cancer treatment, according to a recent study of patients and professionals in major cancer centers across the United States. Led by David Cella, Ph.D., at Evanston Northwestern Healthcare and Northwestern University's cancer center in Chicago, the study confirms not only that cancer-related fatigue is common but also that it affects patients with diverse cancers. Patients undergoing treatment for nine different kinds of advanced cancer ranked it as their most important symptom or concern; patients with two other kinds of cancer ranked it among their top five concerns.

Unfortunately, fatigue is still harder to treat than other common, cancer-related symptoms such as pain and nausea. In this issue of the Journal (1155–1166), Ollie Minton, M.D., of St. George's University of London and colleagues report their findings from a systematic review and meta-analysis of drugs targeted at cancer-related fatigue. Limiting their review . . . [Full Text of this Article]

Defining and Measuring

Current Options

Exercise and Counseling

What Is Fatigue?


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?